Replacement surfactant therapy.
The addition of replacement surfactant therapy to current neonatal intensive care techniques has brought about a significant reduction in the severity of, and mortality from, moderate-to-severe RDS in premature infants. Although exogenous surfactant is relatively easy to administer, its use should be limited to those skilled in handling critically-ill infants on ventilators. While its introduction has been a major step forward, it is not the whole answer to the vexing problem of respiratory distress syndrome.
Greenough
A
A
Department of Child Health, King's College, London.
D006801:Humans; D007231:Infant, Newborn; D011663:Pulmonary Surfactants / Q000008:administration & dosage*; D011859:Radiography; D012127:Respiratory Distress Syndrome, Newborn / Q000000981:diagnostic imaging / Q000188:drug therapy*
D011663:Pulmonary Surfactants